Pandemic Perspectives: COVID’s Unprecedented Experience With Emergency Use Authorizations

 
• By Sarah Karlin-Smith

The US Food and Drug Administration's EUA pathway has seen more use in the therapeutic and vaccine space during the current pandemic than it has in its entire 16-year history and in many cases the potential eligible populations for the authorized products are far larger than past EUAs. Pink Sheet infographic compares details of past and present EUAs.

COVID Causes Exponential Increase in Emergency Use Authorizations
Many EUAs linger after the height of the emergency that sparked their authorizations. • Source: Infogram

More from Review Pathways

More from Pathways & Standards